According to a study, PKM2 suppression with shikonin reduces the effects of lipopolysaccharide-induced AKI by suppressing the production of (Hypoxia-inducible factor 1-alpha) HIF-1 and preventing apoptosis of proximal tubular epithelial cells [29]. The gene discussed is HIF1A; the disease is acute kidney injury.